Purchase Short-Term Access

The Risk for Myocardial Infarction with Cyclooxygenase-2 Inhibitors
Ken Shinmura, MD, PhD; Roberto Bolli, MD
Annals of Internal Medicine 2005;143:617. doi:10.7326/0003-4819-143-8-200510180-00022

Purchase Online access to this article for 24 hours
Buy Now

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.